Adjuvant nivolumab improves disease-free survival (DFS) and overall survival (OS) when compared to placebo in patients with muscle-invasive urothelial carcinoma (MIUC ... The rate of treatment-related ...

Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...

Here, you are in the best hands. Treating you, not just your cancer. With cancer, every detail matters. We customize each aspect of treatment to meet your unique needs. We treat all forms of cancer ...

Enver Cagri Izgu, from the School of Arts and Sciences at Rutgers-New Brunswick, and his team will use a nearly $2 million ...